The group’s principal activities include discovering and developing novel cancer therapeutics. The products of the group include CTK110, CTK-100144 and CTK-000147. Specific customers of the group include Johnson & Johnson, Schering Plough, Fujisawa and Millennium. The group operates from the United States.